Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

Mayass El Ayoubi, Pierre Henri Jarreau, Patrick Van Reempts, Marina Cuttini, Monique Kaminski, Jennifer Zeitlin

Research output: Contribution to journalArticle

Abstract

Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

Original languageEnglish
Pages (from-to)596-601
Number of pages6
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume29
Issue number4
DOIs
Publication statusPublished - Feb 16 2016

Keywords

  • Birthweight percentile
  • bronchopulmonary dysplasia
  • fetal growth restriction
  • in-hospital mortality
  • preterm infants
  • severe neurological morbidity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort'. Together they form a unique fingerprint.

  • Cite this